<!doctype html><html><head><meta charset=utf-8><title>Enlarged Prostate (BPH) and Vitamin D - several studies</title>
<link rel=stylesheet href="/css/main.css?v=1748177519"><link rel=stylesheet href="/css/pagination.css?v=1748177519"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src=https://unpkg.com/lunr/lunr.js></script><script src=https://cdn.jsdelivr.net/npm/pako@2.1.0/dist/pako.min.js></script><script src="/js/search.js?v=1748177519"></script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><h1>Enlarged Prostate (BPH) and Vitamin D - several studies</h1><time>March 2, 2024</time><nav id=TableOfContents><ul><li><ul><li><ul><li><a href=#bph-about-50-more-likely-if-poor-vdr--meta-analysis-march-2024>BPH about 50% more likely if poor VDR – meta-analysis March 2024</a></li></ul></li></ul></li></ul></nav><hr><h4 id=bph-about-50-more-likely-if-poor-vdr--meta-analysis-march-2024>BPH about 50% more likely if poor VDR – meta-analysis March 2024</h4><p><strong>Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis</strong></p><p>Medicine (Baltimore) 2024 Mar 1;103(9):e37361. <a href=https://doi.org/10.1097/MD.0000000000037361.>doi: 10.1097/MD.0000000000037361.</a></p><p>Li Ruan 1</p><p>Background: Benign prostatic hyperplasia (BPH) is one of the global public health challenges due to the complexity of its mechanisms of occurrence. Many studies have suggested that vitamin D receptor gene polymorphisms are associated with BPH susceptibility. Still, their conflicting findings need to be analyzed in aggregate to gain a better understanding.</p><p>Methods: We identified 10 trials involving 1539 BPH cases and 1915 controls through a systematic search of Embase using, data obtained from the Web of Science, PubMed, and China Knowledge Network databases as of December 31, 2021. A meta-analysis was performed to investigate the association between 4 constant polymorphisms of this associated vitamin D receptor gene (Fok-1, Bsm-1, Taq-1, and Apa-1) and BPH risk.</p><p>Results: In the overall population analysis, a significant positive association with BPH risk was found only in the Taq-1 variant (P &lt; .001). Of these, the pure-hybrid model (95% confidence interval <span>[CI]</span> = 1.384-3.196), the heterozygous model (95% CI = 1.207-2.021), the dominant model (95% CI = 1.312-2.133) and the allelic inheritance model (95% CI = 1.205-1.730) showed low heterogeneity. In subtype analyses, Bsm-1 variants showed a significant association with BPH risk for both the recessive (95% CI = 0.100-0.943, P = .039) and over-dominant (95% CI = 1.553-3.100, P = 0) models in the Caucasian population, and for the recessive (95% CI = 1.242-3.283, P = .039) and over-dominant (95% CI = 0.281-0.680, P = 0) models in the Asian population. In addition, a high degree of heterogeneity was found in the subgroup analysis of the association between Fok-1 variants and BPH risk.</p><p>Conclusion: Overall, there is an association between vitamin D receptor polymorphisms and BPH risk. Identification of BPH susceptibility by vitamin D receptor gene polymorphisms has potential.</p><h5 id=31-references>31 References</h5><ul><li><p>Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to <strong>benign prostatic hyperplasia:</strong> AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.</p></li><li><p>Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.</p></li><li><p>Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.</p></li><li><p>Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). <strong>prostate</strong> . 2017;77:1213–20.</p></li><li><p>AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of <strong>vitamin D receptor</strong> gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.</p></li><li><p>Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.</p></li><li><p>Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai <strong>prostate</strong> cancer as compared with benign <strong>prostate</strong> hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.</p></li><li><p>Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the <strong>vitamin D receptor</strong> (VDR) gene (Fok-1, Taq-1 & Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.</p></li><li><p>Zeng XT, Yao QS, Weng H, et al. Meta-analysis of <strong>vitamin D receptor</strong> gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.</p></li><li><p>Lu C, Zhou W, He X, et al. Vitamin D status and <strong>vitamin D receptor</strong> genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.</p></li><li><p>Barry EL, Peacock JL, Rees JR, et al. <strong>vitamin D receptor</strong> genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.</p></li><li><p>Latacz M, Rozmus D, Fiedorowicz E, et al. <strong>vitamin D receptor</strong> (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.</p></li><li><p>Huang SP, Huang CY, Wu WJ, et al. Association of <strong>vitamin D receptor</strong> Fok-1 polymorphism with <strong>prostate</strong> cancer risk, clinicopathological features and recurrence of <strong>prostate</strong> specific antigen after radical <strong>prostate</strong> ctomy. Int J Cancer. 2006;119:1902–7.</p></li><li><p>Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of <strong>vitamin D receptor</strong> and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.</p></li><li><p>Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the <strong>vitamin D receptor</strong> gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.</p></li><li><p>El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign <strong>prostate</strong> hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.</p></li><li><p>Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of <strong>benign prostatic hyperplasia:</strong> a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.</p></li><li><p>Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of <strong>vitamin D receptor</strong> gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.</p></li><li><p>Schatzl G, Gsur A, Bernhofer G, et al. Association of <strong>vitamin D receptor</strong> and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.</p></li><li><p>Habuchi T, Suzuki T, Sasaki R, et al. Association of <strong>vitamin D receptor</strong> gene polymorphism with <strong>prostate</strong> cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.</p></li><li><p>Nunes SBR, Oliveira FM, Neves AF, et al. Association of <strong>vitamin D receptor</strong> variants with clinical parameters in <strong>prostate</strong> cancer. Springerplus. 2016;5:364.</p></li><li><p>Hamasaki T, Inatomi H, Katoh T, et al. Significance of <strong>vitamin D receptor</strong> gene polymorphism for risk and disease severity of <strong>prostate</strong> cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.</p></li><li><p>Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.</p></li><li><p>Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with <strong>prostate</strong> cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.</p></li><li><p>Manchanda PK, Kibler AJ, Zhang M, et al. <strong>vitamin D receptor</strong> as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.</p></li><li><p>Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign <strong>prostate</strong> hyperplasia. Syst Rev. 2022;11:60.</p></li><li><p>Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and <strong>vitamin D receptor</strong> polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.</p></li><li><p>Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.</p></li><li><p>Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the <strong>prostate</strong> : implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.</p></li><li><p>Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.</p></li><li><p>Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.</p></li></ul><pre style=background-color:#e0e0e0;white-space:pre-wrap>
<code class=language-text>
Markdown:
--------
{{&lt; toc &gt;}}

---

#### BPH about 50% more likely if poor VDR – meta-analysis March 2024

 **Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis** 

Medicine (Baltimore) 2024 Mar 1;103(9):e37361. [doi: 10.1097/MD.0000000000037361.](https://doi.org/10.1097/MD.0000000000037361.)

Li Ruan 1

Background: Benign prostatic hyperplasia (BPH) is one of the global public health challenges due to the complexity of its mechanisms of occurrence. Many studies have suggested that vitamin D receptor gene polymorphisms are associated with BPH susceptibility. Still, their conflicting findings need to be analyzed in aggregate to gain a better understanding.

Methods: We identified 10 trials involving 1539 BPH cases and 1915 controls through a systematic search of Embase using, data obtained from the Web of Science, PubMed, and China Knowledge Network databases as of December 31, 2021. A meta-analysis was performed to investigate the association between 4 constant polymorphisms of this associated vitamin D receptor gene (Fok-1, Bsm-1, Taq-1, and Apa-1) and BPH risk.

Results: In the overall population analysis, a significant positive association with BPH risk was found only in the Taq-1 variant (P &lt; .001). Of these, the pure-hybrid model (95% confidence interval &lt;span&gt;[CI]&lt;/span&gt; = 1.384-3.196), the heterozygous model (95% CI = 1.207-2.021), the dominant model (95% CI = 1.312-2.133) and the allelic inheritance model (95% CI = 1.205-1.730) showed low heterogeneity. In subtype analyses, Bsm-1 variants showed a significant association with BPH risk for both the recessive (95% CI = 0.100-0.943, P = .039) and over-dominant (95% CI = 1.553-3.100, P = 0) models in the Caucasian population, and for the recessive (95% CI = 1.242-3.283, P = .039) and over-dominant (95% CI = 0.281-0.680, P = 0) models in the Asian population. In addition, a high degree of heterogeneity was found in the subgroup analysis of the association between Fok-1 variants and BPH risk.

Conclusion: Overall, there is an association between vitamin D receptor polymorphisms and BPH risk. Identification of BPH susceptibility by vitamin D receptor gene polymorphisms has potential.

##### 31 References

* Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to **benign prostatic hyperplasia:**  AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.

* Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.

* Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.

* Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS).  **prostate** . 2017;77:1213–20.

* AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of  **vitamin D receptor**  gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.

* Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.

* Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai  **prostate**  cancer as compared with benign  **prostate**  hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.

* Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the  **vitamin D receptor**  (VDR) gene (Fok-1, Taq-1 &amp; Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.

* Zeng XT, Yao QS, Weng H, et al. Meta-analysis of  **vitamin D receptor**  gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.

* Lu C, Zhou W, He X, et al. Vitamin D status and  **vitamin D receptor**  genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.

* Barry EL, Peacock JL, Rees JR, et al.  **vitamin D receptor**  genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.

* Latacz M, Rozmus D, Fiedorowicz E, et al.  **vitamin D receptor**  (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.

* Huang SP, Huang CY, Wu WJ, et al. Association of  **vitamin D receptor**  Fok-1 polymorphism with  **prostate**  cancer risk, clinicopathological features and recurrence of  **prostate**  specific antigen after radical  **prostate** ctomy. Int J Cancer. 2006;119:1902–7.

* Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of  **vitamin D receptor**  and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.

* Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the  **vitamin D receptor**  gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.

* El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign  **prostate**  hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.

* Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of **benign prostatic hyperplasia:**  a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.

* Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of  **vitamin D receptor**  gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.

* Schatzl G, Gsur A, Bernhofer G, et al. Association of  **vitamin D receptor**  and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.

* Habuchi T, Suzuki T, Sasaki R, et al. Association of  **vitamin D receptor**  gene polymorphism with  **prostate**  cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.

* Nunes SBR, Oliveira FM, Neves AF, et al. Association of  **vitamin D receptor**  variants with clinical parameters in  **prostate**  cancer. Springerplus. 2016;5:364.

* Hamasaki T, Inatomi H, Katoh T, et al. Significance of  **vitamin D receptor**  gene polymorphism for risk and disease severity of  **prostate**  cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.

* Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.

* Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with  **prostate**  cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.

* Manchanda PK, Kibler AJ, Zhang M, et al.  **vitamin D receptor**  as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.

* Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign  **prostate**  hyperplasia. Syst Rev. 2022;11:60.

* Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and  **vitamin D receptor**  polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.

* Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.

* Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the  **prostate** : implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.

* Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.

* Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.


AST Structure:
-------------
├── DivNode
│   full_match: `{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}`
│   inner_content: `{maketoc Title=&quot;&quot;}`
│   attrs_dict:
│   │   raw_content: (class=&quot;lefth4&quot;)
│   │   class: lefth4
│   children:
│   ├── MakeTocNode
│   │   full_match: `{maketoc Title=&quot;&quot;}`
│   │   inner_content: ``
│   │   attrs_dict:
│   │   │   raw_content:  Title=&quot;&quot;
│   │   │   Title: ├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!~~#F00:4+~~ VitaminDWiki pages have BPH in the title`
│   inner_content: `~~#F00:4+~~ VitaminDWiki pages have BPH in the title`
│   level: `4`
│   children:
│   ├── ColorNode
│   │   full_match: `~~#F00:4+~~`
│   │   inner_content: `4+`
│   │   attrs_dict:
│   │   │   raw_content: #F00
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `4+`
│   │   │   inner_content: `4+`
│   ├── TextNode
│   │   full_match: ` VitaminDWiki pages have BPH in the title`
│   │   inner_content: ` VitaminDWiki pages have BPH in the title`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── EmphasisNode
│   full_match: `&#39;&#39;This list is automatically updated&#39;&#39;`
│   inner_content: `This list is automatically updated`
│   children:
│   ├── TextNode
│   │   full_match: `This list is automatically updated`
│   │   inner_content: `This list is automatically updated`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListNode
│   full_match: `{LIST()}\n{list max=&quot;150&quot;}\n{filter field=&quot;title&quot; content=&quot;BPH&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n{LIST}`
│   inner_content: `\n{list max=&quot;150&quot;}\n{filter field=&quot;title&quot; content=&quot;BPH&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n`
│   attrs_dict:
│   │   raw_content: 
│   children:
│   ├── TextNode
│   │   full_match: `\n{list max=&quot;150&quot;}\n{filter field=&quot;title&quot; content=&quot;BPH&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n`
│   │   inner_content: `\n{list max=&quot;150&quot;}\n{filter field=&quot;title&quot; content=&quot;BPH&quot;}\n{filter type=&quot;wiki page&quot;}\n{sort mode=&quot;modification_date_major_desc&quot;}\n{OUTPUT(template=&quot;table&quot;)}\n{tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}\n{column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}\n{column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}\n{OUTPUT}\n{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}\n{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}\n`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!BPH about 50% more likely if poor VDR – meta-analysis March 2024`
│   inner_content: `BPH about 50% more likely if poor VDR – meta-analysis March 2024`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `BPH about 50% more likely if poor VDR – meta-analysis March 2024`
│   │   inner_content: `BPH about 50% more likely if poor VDR – meta-analysis March 2024`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── BoldNode
│   full_match: `__Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis__`
│   inner_content: `Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis`
│   children:
│   ├── TextNode
│   │   full_match: `Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis`
│   │   inner_content: `Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis`├── TextNode
│   full_match: `\nMedicine (Baltimore) 2024 Mar 1;103(9):e37361. `
│   inner_content: `\nMedicine (Baltimore) 2024 Mar 1;103(9):e37361. `├── DoiLinkNode
│   full_match: `doi: 10.1097/MD.0000000000037361.`
│   inner_content: `10.1097/MD.0000000000037361.`├── TextNode
│   full_match: `\nLi Ruan 1\n\nBackground: Benign prostatic hyperplasia (BPH) is one of the global public health challenges due to the complexity of its mechanisms of occurrence. Many studies have suggested that vitamin D receptor gene polymorphisms are associated with BPH susceptibility. Still, their conflicting findings need to be analyzed in aggregate to gain a better understanding.\n\nMethods: We identified 10 trials involving 1539 BPH cases and 1915 controls through a systematic search of Embase using, data obtained from the Web of Science, PubMed, and China Knowledge Network databases as of December 31, 2021. A meta-analysis was performed to investigate the association between 4 constant polymorphisms of this associated vitamin D receptor gene (Fok-1, Bsm-1, Taq-1, and Apa-1) and BPH risk.\n\nResults: In the overall population analysis, a significant positive association with BPH risk was found only in the Taq-1 variant (P &lt; .001). Of these, the pure-hybrid model (95% confidence interval `
│   inner_content: `\nLi Ruan 1\n\nBackground: Benign prostatic hyperplasia (BPH) is one of the global public health challenges due to the complexity of its mechanisms of occurrence. Many studies have suggested that vitamin D receptor gene polymorphisms are associated with BPH susceptibility. Still, their conflicting findings need to be analyzed in aggregate to gain a better understanding.\n\nMethods: We identified 10 trials involving 1539 BPH cases and 1915 controls through a systematic search of Embase using, data obtained from the Web of Science, PubMed, and China Knowledge Network databases as of December 31, 2021. A meta-analysis was performed to investigate the association between 4 constant polymorphisms of this associated vitamin D receptor gene (Fok-1, Bsm-1, Taq-1, and Apa-1) and BPH risk.\n\nResults: In the overall population analysis, a significant positive association with BPH risk was found only in the Taq-1 variant (P &lt; .001). Of these, the pure-hybrid model (95% confidence interval `├── LinkNode
│   full_match: `[CI]`
│   inner_content: `CI`
│   url: `CI`
│   children:
│   ├── TextNode
│   │   full_match: `CI`
│   │   inner_content: `CI`├── TextNode
│   full_match: ` = 1.384-3.196), the heterozygous model (95% CI = 1.207-2.021), the dominant model (95% CI = 1.312-2.133) and the allelic inheritance model (95% CI = 1.205-1.730) showed low heterogeneity. In subtype analyses, Bsm-1 variants showed a significant association with BPH risk for both the recessive (95% CI = 0.100-0.943, P = .039) and over-dominant (95% CI = 1.553-3.100, P = 0) models in the Caucasian population, and for the recessive (95% CI = 1.242-3.283, P = .039) and over-dominant (95% CI = 0.281-0.680, P = 0) models in the Asian population. In addition, a high degree of heterogeneity was found in the subgroup analysis of the association between Fok-1 variants and BPH risk.\n\nConclusion: Overall, there is an association between vitamin D receptor polymorphisms and BPH risk. Identification of BPH susceptibility by vitamin D receptor gene polymorphisms has potential.\n`
│   inner_content: ` = 1.384-3.196), the heterozygous model (95% CI = 1.207-2.021), the dominant model (95% CI = 1.312-2.133) and the allelic inheritance model (95% CI = 1.205-1.730) showed low heterogeneity. In subtype analyses, Bsm-1 variants showed a significant association with BPH risk for both the recessive (95% CI = 0.100-0.943, P = .039) and over-dominant (95% CI = 1.553-3.100, P = 0) models in the Caucasian population, and for the recessive (95% CI = 1.242-3.283, P = .039) and over-dominant (95% CI = 0.281-0.680, P = 0) models in the Asian population. In addition, a high degree of heterogeneity was found in the subgroup analysis of the association between Fok-1 variants and BPH risk.\n\nConclusion: Overall, there is an association between vitamin D receptor polymorphisms and BPH risk. Identification of BPH susceptibility by vitamin D receptor gene polymorphisms has potential.\n`├── HeadingNode
│   full_match: `\n!!!!!31 References`
│   inner_content: `31 References`
│   level: `5`
│   children:
│   ├── TextNode
│   │   full_match: `31 References`
│   │   inner_content: `31 References`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to__ benign prostatic hyperplasia:__ AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.`
│   inner_content: `Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to__ benign prostatic hyperplasia:__ AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to`
│   │   inner_content: `Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to`
│   ├── BoldNode
│   │   full_match: `__ benign prostatic hyperplasia:__`
│   │   inner_content: ` benign prostatic hyperplasia:`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `benign prostatic hyperplasia:`
│   │   │   inner_content: `benign prostatic hyperplasia:`
│   ├── TextNode
│   │   full_match: ` AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.`
│   │   inner_content: ` AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.`
│   inner_content: `Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.`
│   │   inner_content: `Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.`
│   inner_content: `Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.`
│   │   inner_content: `Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). __prostate__. 2017;77:1213–20.`
│   inner_content: `Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). __prostate__. 2017;77:1213–20.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). `
│   │   inner_content: `Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: `. 2017;77:1213–20.`
│   │   inner_content: `. 2017;77:1213–20.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of __vitamin D receptor__ gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.`
│   inner_content: `AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of __vitamin D receptor__ gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of `
│   │   inner_content: `AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.`
│   │   inner_content: ` gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.`
│   inner_content: `Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.`
│   │   inner_content: `Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai __prostate__ cancer as compared with benign __prostate__ hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.`
│   inner_content: `Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai __prostate__ cancer as compared with benign __prostate__ hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai `
│   │   inner_content: `Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` cancer as compared with benign `
│   │   inner_content: ` cancer as compared with benign `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.`
│   │   inner_content: ` hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the __vitamin D receptor__ (VDR) gene (Fok-1, Taq-1 &amp; Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.`
│   inner_content: `Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the __vitamin D receptor__ (VDR) gene (Fok-1, Taq-1 &amp; Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the `
│   │   inner_content: `Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` (VDR) gene (Fok-1, Taq-1 &amp; Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.`
│   │   inner_content: ` (VDR) gene (Fok-1, Taq-1 &amp; Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Zeng XT, Yao QS, Weng H, et al. Meta-analysis of __vitamin D receptor__ gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.`
│   inner_content: `Zeng XT, Yao QS, Weng H, et al. Meta-analysis of __vitamin D receptor__ gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zeng XT, Yao QS, Weng H, et al. Meta-analysis of `
│   │   inner_content: `Zeng XT, Yao QS, Weng H, et al. Meta-analysis of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.`
│   │   inner_content: ` gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Lu C, Zhou W, He X, et al. Vitamin D status and __vitamin D receptor__ genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.`
│   inner_content: `Lu C, Zhou W, He X, et al. Vitamin D status and __vitamin D receptor__ genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lu C, Zhou W, He X, et al. Vitamin D status and `
│   │   inner_content: `Lu C, Zhou W, He X, et al. Vitamin D status and `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.`
│   │   inner_content: ` genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Barry EL, Peacock JL, Rees JR, et al. __vitamin D receptor__ genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.`
│   inner_content: `Barry EL, Peacock JL, Rees JR, et al. __vitamin D receptor__ genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Barry EL, Peacock JL, Rees JR, et al. `
│   │   inner_content: `Barry EL, Peacock JL, Rees JR, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.`
│   │   inner_content: ` genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Latacz M, Rozmus D, Fiedorowicz E, et al. __vitamin D receptor__ (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.`
│   inner_content: `Latacz M, Rozmus D, Fiedorowicz E, et al. __vitamin D receptor__ (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Latacz M, Rozmus D, Fiedorowicz E, et al. `
│   │   inner_content: `Latacz M, Rozmus D, Fiedorowicz E, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.`
│   │   inner_content: ` (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Huang SP, Huang CY, Wu WJ, et al. Association of __vitamin D receptor__ Fok-1 polymorphism with __prostate__ cancer risk, clinicopathological features and recurrence of __prostate__ specific antigen after radical __prostate__ctomy. Int J Cancer. 2006;119:1902–7.`
│   inner_content: `Huang SP, Huang CY, Wu WJ, et al. Association of __vitamin D receptor__ Fok-1 polymorphism with __prostate__ cancer risk, clinicopathological features and recurrence of __prostate__ specific antigen after radical __prostate__ctomy. Int J Cancer. 2006;119:1902–7.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Huang SP, Huang CY, Wu WJ, et al. Association of `
│   │   inner_content: `Huang SP, Huang CY, Wu WJ, et al. Association of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` Fok-1 polymorphism with `
│   │   inner_content: ` Fok-1 polymorphism with `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` cancer risk, clinicopathological features and recurrence of `
│   │   inner_content: ` cancer risk, clinicopathological features and recurrence of `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` specific antigen after radical `
│   │   inner_content: ` specific antigen after radical `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: `ctomy. Int J Cancer. 2006;119:1902–7.`
│   │   inner_content: `ctomy. Int J Cancer. 2006;119:1902–7.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of __vitamin D receptor__ and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.`
│   inner_content: `Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of __vitamin D receptor__ and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of `
│   │   inner_content: `Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.`
│   │   inner_content: ` and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the __vitamin D receptor__ gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.`
│   inner_content: `Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the __vitamin D receptor__ gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the `
│   │   inner_content: `Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.`
│   │   inner_content: ` gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign __prostate__ hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.`
│   inner_content: `El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign __prostate__ hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign `
│   │   inner_content: `El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.`
│   │   inner_content: ` hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of__ benign prostatic hyperplasia:__ a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.`
│   inner_content: `Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of__ benign prostatic hyperplasia:__ a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of`
│   │   inner_content: `Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of`
│   ├── BoldNode
│   │   full_match: `__ benign prostatic hyperplasia:__`
│   │   inner_content: ` benign prostatic hyperplasia:`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `benign prostatic hyperplasia:`
│   │   │   inner_content: `benign prostatic hyperplasia:`
│   ├── TextNode
│   │   full_match: ` a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.`
│   │   inner_content: ` a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of __vitamin D receptor__ gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.`
│   inner_content: `Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of __vitamin D receptor__ gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of `
│   │   inner_content: `Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.`
│   │   inner_content: ` gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Schatzl G, Gsur A, Bernhofer G, et al. Association of __vitamin D receptor__ and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.`
│   inner_content: `Schatzl G, Gsur A, Bernhofer G, et al. Association of __vitamin D receptor__ and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Schatzl G, Gsur A, Bernhofer G, et al. Association of `
│   │   inner_content: `Schatzl G, Gsur A, Bernhofer G, et al. Association of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.`
│   │   inner_content: ` and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Habuchi T, Suzuki T, Sasaki R, et al. Association of __vitamin D receptor__ gene polymorphism with __prostate__ cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.`
│   inner_content: `Habuchi T, Suzuki T, Sasaki R, et al. Association of __vitamin D receptor__ gene polymorphism with __prostate__ cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Habuchi T, Suzuki T, Sasaki R, et al. Association of `
│   │   inner_content: `Habuchi T, Suzuki T, Sasaki R, et al. Association of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` gene polymorphism with `
│   │   inner_content: ` gene polymorphism with `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.`
│   │   inner_content: ` cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Nunes SBR, Oliveira FM, Neves AF, et al. Association of __vitamin D receptor__ variants with clinical parameters in __prostate__ cancer. Springerplus. 2016;5:364.`
│   inner_content: `Nunes SBR, Oliveira FM, Neves AF, et al. Association of __vitamin D receptor__ variants with clinical parameters in __prostate__ cancer. Springerplus. 2016;5:364.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Nunes SBR, Oliveira FM, Neves AF, et al. Association of `
│   │   inner_content: `Nunes SBR, Oliveira FM, Neves AF, et al. Association of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` variants with clinical parameters in `
│   │   inner_content: ` variants with clinical parameters in `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` cancer. Springerplus. 2016;5:364.`
│   │   inner_content: ` cancer. Springerplus. 2016;5:364.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Hamasaki T, Inatomi H, Katoh T, et al. Significance of __vitamin D receptor__ gene polymorphism for risk and disease severity of __prostate__ cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.`
│   inner_content: `Hamasaki T, Inatomi H, Katoh T, et al. Significance of __vitamin D receptor__ gene polymorphism for risk and disease severity of __prostate__ cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Hamasaki T, Inatomi H, Katoh T, et al. Significance of `
│   │   inner_content: `Hamasaki T, Inatomi H, Katoh T, et al. Significance of `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` gene polymorphism for risk and disease severity of `
│   │   inner_content: ` gene polymorphism for risk and disease severity of `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.`
│   │   inner_content: ` cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.`
│   inner_content: `Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.`
│   │   inner_content: `Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with __prostate__ cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.`
│   inner_content: `Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with __prostate__ cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with `
│   │   inner_content: `Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.`
│   │   inner_content: ` cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Manchanda PK, Kibler AJ, Zhang M, et al. __vitamin D receptor__ as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.`
│   inner_content: `Manchanda PK, Kibler AJ, Zhang M, et al. __vitamin D receptor__ as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Manchanda PK, Kibler AJ, Zhang M, et al. `
│   │   inner_content: `Manchanda PK, Kibler AJ, Zhang M, et al. `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.`
│   │   inner_content: ` as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign __prostate__ hyperplasia. Syst Rev. 2022;11:60.`
│   inner_content: `Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign __prostate__ hyperplasia. Syst Rev. 2022;11:60.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign `
│   │   inner_content: `Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: ` hyperplasia. Syst Rev. 2022;11:60.`
│   │   inner_content: ` hyperplasia. Syst Rev. 2022;11:60.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and __vitamin D receptor__ polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.`
│   inner_content: `Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and __vitamin D receptor__ polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and `
│   │   inner_content: `Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and `
│   ├── BoldNode
│   │   full_match: `__vitamin D receptor__`
│   │   inner_content: `vitamin D receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `vitamin D receptor`
│   │   │   inner_content: `vitamin D receptor`
│   ├── TextNode
│   │   full_match: ` polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.`
│   │   inner_content: ` polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.`
│   inner_content: `Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.`
│   │   inner_content: `Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the __prostate__: implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.`
│   inner_content: `Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the __prostate__: implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the `
│   │   inner_content: `Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the `
│   ├── BoldNode
│   │   full_match: `__prostate__`
│   │   inner_content: `prostate`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `prostate`
│   │   │   inner_content: `prostate`
│   ├── TextNode
│   │   full_match: `: implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.`
│   │   inner_content: `: implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.`
│   inner_content: `Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.`
│   │   inner_content: `Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── ListItemNode
│   full_match: `*Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.`
│   inner_content: `Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.`
│   depth: `1`
│   children:
│   ├── TextNode
│   │   full_match: `Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.`
│   │   inner_content: `Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.`├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki - ((Vitamin D Receptor)) activation can be increased in many ways`
│   inner_content: `VitaminDWiki - ((Vitamin D Receptor)) activation can be increased in many ways`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki - `
│   │   inner_content: `VitaminDWiki - `
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D Receptor))`
│   │   inner_content: `Vitamin D Receptor`
│   │   page: `Vitamin D Receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D Receptor`
│   │   │   inner_content: `Vitamin D Receptor`
│   ├── TextNode
│   │   full_match: ` activation can be increased in many ways`
│   │   inner_content: ` activation can be increased in many ways`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Vitamin D Receptor&quot; start=&quot;~tc~ startact ~/tc~&quot; stop=&quot;~tc~ endact ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Vitamin D Receptor&quot; start=&quot;~tc~ startact ~/tc~&quot; stop=&quot;~tc~ endact ~/tc~&quot;
│   │   page: Vitamin D Receptor
│   │   start: ~tc~ startact ~/tc~
│   │   stop: ~tc~ endact ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``├── HorizontalRuleNode
│   full_match: `\n---\n`
│   inner_content: `---`├── HeadingNode
│   full_match: `!!!!VitaminDWiki – ((Vitamin D Receptor)) category contains`
│   inner_content: `VitaminDWiki – ((Vitamin D Receptor)) category contains`
│   level: `4`
│   children:
│   ├── TextNode
│   │   full_match: `VitaminDWiki – `
│   │   inner_content: `VitaminDWiki – `
│   ├── LocalLinkNode
│   │   full_match: `((Vitamin D Receptor))`
│   │   inner_content: `Vitamin D Receptor`
│   │   page: `Vitamin D Receptor`
│   │   children:
│   │   ├── TextNode
│   │   │   full_match: `Vitamin D Receptor`
│   │   │   inner_content: `Vitamin D Receptor`
│   ├── TextNode
│   │   full_match: ` category contains`
│   │   inner_content: ` category contains`├── TextNode
│   full_match: `\n`
│   inner_content: `\n`├── IncludeNode
│   full_match: `{include page=&quot;Vitamin D Receptor&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}`
│   inner_content: ``
│   attrs_dict:
│   │   raw_content:  page=&quot;Vitamin D Receptor&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;
│   │   page: Vitamin D Receptor
│   │   start: ~tc~ start ~/tc~
│   │   stop: ~tc~ end ~/tc~
│   children:
│   ├── TextNode
│   │   full_match: ``
│   │   inner_content: ``

Original Tiki:
-------------
{DIV(class=&quot;lefth4&quot;)}{maketoc Title=&quot;&quot;}{DIV}
---
!!!!~~#F00:4+~~ VitaminDWiki pages have BPH in the title
&#39;&#39;This list is automatically updated&#39;&#39;
{LIST()}
{list max=&quot;150&quot;}
{filter field=&quot;title&quot; content=&quot;BPH&quot;}
{filter type=&quot;wiki page&quot;}
{sort mode=&quot;modification_date_major_desc&quot;}
{OUTPUT(template=&quot;table&quot;)}
   {tableparams allowtableexpansion=&quot;n&quot; shownbitems=&quot;y&quot; title=&quot;&quot;}
    {column sort=&quot;title&quot; label=&quot;Title&quot; field=&quot;title&quot; mode=&quot;raw&quot;}{column}
    {column label=&quot;Modified&quot; sort=&quot;modification_date_major&quot; field=&quot;modification_date_major&quot;}
{OUTPUT}
{FORMAT(name=&quot;title&quot;)}{display name=title format=&quot;objectlink&quot;}{FORMAT}
{FORMAT(name=&quot;modification_date_major&quot;)}{display name=modification_date_major format=&quot;date&quot;}{FORMAT}
{LIST}
---
!!!!BPH about 50% more likely if poor VDR – meta-analysis March 2024
__Association between vitamin D receptor gene polymorphisms and genetic susceptibility to benign prostatic hyperplasia: A systematic review and meta-analysis__
Medicine (Baltimore) 2024 Mar 1;103(9):e37361. doi: 10.1097/MD.0000000000037361.
Li Ruan 1

Background: Benign prostatic hyperplasia (BPH) is one of the global public health challenges due to the complexity of its mechanisms of occurrence. Many studies have suggested that vitamin D receptor gene polymorphisms are associated with BPH susceptibility. Still, their conflicting findings need to be analyzed in aggregate to gain a better understanding.

Methods: We identified 10 trials involving 1539 BPH cases and 1915 controls through a systematic search of Embase using, data obtained from the Web of Science, PubMed, and China Knowledge Network databases as of December 31, 2021. A meta-analysis was performed to investigate the association between 4 constant polymorphisms of this associated vitamin D receptor gene (Fok-1, Bsm-1, Taq-1, and Apa-1) and BPH risk.

Results: In the overall population analysis, a significant positive association with BPH risk was found only in the Taq-1 variant (P &lt; .001). Of these, the pure-hybrid model (95% confidence interval [CI] = 1.384-3.196), the heterozygous model (95% CI = 1.207-2.021), the dominant model (95% CI = 1.312-2.133) and the allelic inheritance model (95% CI = 1.205-1.730) showed low heterogeneity. In subtype analyses, Bsm-1 variants showed a significant association with BPH risk for both the recessive (95% CI = 0.100-0.943, P = .039) and over-dominant (95% CI = 1.553-3.100, P = 0) models in the Caucasian population, and for the recessive (95% CI = 1.242-3.283, P = .039) and over-dominant (95% CI = 0.281-0.680, P = 0) models in the Asian population. In addition, a high degree of heterogeneity was found in the subgroup analysis of the association between Fok-1 variants and BPH risk.

Conclusion: Overall, there is an association between vitamin D receptor polymorphisms and BPH risk. Identification of BPH susceptibility by vitamin D receptor gene polymorphisms has potential.

!!!!!31 References
*Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to__ benign prostatic hyperplasia:__ AUA GUIDELINE PART I—initial work-up and medical management. J Urol. 2021;206:806–17.
*Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia—what do we know? BJU Int. 2021;127:389–99.
*Qian XQ, Xu D, Liu HL, et al. Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the alpha-adrenergic receptor antagonist. Aging Male. 2017;20:250–6.
*Na R, Helfand BT, Chen HT, et al. A genetic variant near GATA3 implicated in inherited susceptibility and etiology of benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). __prostate__. 2017;77:1213–20.
*AlChalabi R, Wali MH, Al-Ugaili DN, et al. Association between single nucleotide polymorphisms of __vitamin D receptor__ gene and diabetes with progression of benign prostatic hyperplasia. Ann Trop Med Public Health. 2020;23:444–54.
*Kayode OT, Owolabi AV, Kayode AAA. Biochemical and histomorphological changes in testosterone propionate-induced benign prostatic hyperplasia in male Wistar rats treated with ketogenic diet. Biomed Pharmacother. 2020;132:110863.
*Chaimuangraj S, Thammachoti R, Ongphiphadhanakul B, et al. Lack of association of VDR polymorphisms with Thai __prostate__ cancer as compared with benign __prostate__ hyperplasia and controls. Asian Pac J Cancer Prev. 2006;7:136–9.
*Manchanda PK, Konwar R, Nayak VL, et al. Association of genetic variants of the __vitamin D receptor__ (VDR) gene (Fok-1, Taq-1 &amp; Bsm-1) with susceptibility of benign prostatic hyperplasia in a North Indian population. Asian Pac J Cancer Prev. 2010;11:1005–8.
*Zeng XT, Yao QS, Weng H, et al. Meta-analysis of __vitamin D receptor__ gene polymorphisms and benign prostatic hyperplasia risk. Mol Biol Rep. 2014;41:6713–7.
*Lu C, Zhou W, He X, et al. Vitamin D status and __vitamin D receptor__ genotypes in celiac disease: a meta-analysis. Crit Rev Food Sci Nutr. 2021;61:2098–106.
*Barry EL, Peacock JL, Rees JR, et al. __vitamin D receptor__ genotype, vitamin D3 supplementation, and risk of colorectal adenomas: a randomized clinical trial. JAMA Oncol. 2017;3:628–35.
*Latacz M, Rozmus D, Fiedorowicz E, et al. __vitamin D receptor__ (VDR) gene polymorphism in patients diagnosed with colorectal cancer. Nutrients. 2021;13:200.
*Huang SP, Huang CY, Wu WJ, et al. Association of __vitamin D receptor__ Fok-1 polymorphism with __prostate__ cancer risk, clinicopathological features and recurrence of __prostate__ specific antigen after radical __prostate__ctomy. Int J Cancer. 2006;119:1902–7.
*Zhou Q, Wen S, Liu M, et al. Association between gene polymorphisms of __vitamin D receptor__ and gestational diabetes mellitus: a systematic review and meta-analysis. Int J Environ Res Public Health. 2020;18:205.
*Bousemaa JT, Bussemakers MJG, Houwelingen KP, et al. Polymorphisms in the __vitamin D receptor__ gene and the androgen receptor gene and the risk of benign prostatic hyperplasia. Eur Urol. 2000;37:234–8.
*El-Ezzi AA, Zaidan WR, El-Saidi MA, et al. Association of benign __prostate__ hyperplasia with polymorphisms in VDR, CYP17, and SRD5A2 genes among Lebanese men. Asian Pac J Cancer Prev. 2014;15:1255–62.
*Zhang LL, Song Y, He LL, et al. Associations of SRD5A2/CYP17/CYP19/VDR gene polymorphisms with the development and clinical progression of__ benign prostatic hyperplasia:__ a case-control study in northern Chinese population. Int J Clin Exp Pathol. 2017;10:8660–76.
*Ruan L, Zhu JG, Pan C, et al. Association between single nucleotide polymorphism of __vitamin D receptor__ gene Fok-1 polymorphism and clinical progress of benign prostatic hyperplasia. ScientificWorldJournal. 2015;2015:235895.
*Schatzl G, Gsur A, Bernhofer G, et al. Association of __vitamin D receptor__ and 17 Hydroxylase Gene polymorphisms with benign prostatic hyperplasia and Benign prostatic enlargement. Urology. 2000;57:567–72.
*Habuchi T, Suzuki T, Sasaki R, et al. Association of __vitamin D receptor__ gene polymorphism with __prostate__ cancer and benign prostatic hyperplasia in a Japanese population. Cancer Res. 2000;60:305–8.
*Nunes SBR, Oliveira FM, Neves AF, et al. Association of __vitamin D receptor__ variants with clinical parameters in __prostate__ cancer. Springerplus. 2016;5:364.
*Hamasaki T, Inatomi H, Katoh T, et al. Significance of __vitamin D receptor__ gene polymorphism for risk and disease severity of __prostate__ cancer and benign prostatic hyperplasia in Japanese. Urol Int. 2002;68:226–31.
*Lee Ch L, Lee J, Na YJ, et al. Combined effect of polymorphisms in type III 5-α reductase and androgen receptor gene with the risk of benign prostatic hyperplasia in Korea. J Exerc Rehabil. 2016;12:504–8.
*Taheri M, Pouresmaeili F, Omrani MD, et al. Association of ANRIL gene polymorphisms with __prostate__ cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med. 2017;11:413–22.
*Manchanda PK, Kibler AJ, Zhang M, et al. __vitamin D receptor__ as a therapeutic target for benign prostatic hyperplasia. Indian J Urol. 2012;28:377–81.
*Lin L, Li P, Liu X, et al. Systematic review and meta-analysis of candidate gene association studies of benign __prostate__ hyperplasia. Syst Rev. 2022;11:60.
*Mullan RJ, Bergstralh EJ, Farmer SA, et al. Growth factor, cytokine, and __vitamin D receptor__ polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men. Urology. 2006;67:300–5.
*Kim SK, Chung JH, Park HC, et al. Association between polymorphisms of estrogen receptor 2 and benign prostatic hyperplasia. Exp Ther Med. 2015;10:1990–4.
*Swami S, Krishnan AV, Feldman D. Vitamin D metabolism and action in the __prostate__: implications for health and disease. Mol Cell Endocrinol. 2011;347:61–9.
*Ruiz-Ballesteros AI, Meza-Meza MR, Vizmanos-Lamotte B, et al. Association of vitamin D metabolism gene polymorphisms with autoimmunity: evidence in population genetic studies. Int J Mol Sci. 2020;21:9626.
*Brustad N, Greve JH, Mirzakhani H, et al. High-dose vitamin D during pregnancy and pathway gene polymorphisms in prevention of offspring persistent wheeze. Pediatr Allergy Immunol. 2021;32:679–89.
---
!!!!VitaminDWiki - ((Vitamin D Receptor)) activation can be increased in many ways
{include page=&quot;Vitamin D Receptor&quot; start=&quot;~tc~ startact ~/tc~&quot; stop=&quot;~tc~ endact ~/tc~&quot;}
---
!!!!VitaminDWiki – ((Vitamin D Receptor)) category contains
{include page=&quot;Vitamin D Receptor&quot; start=&quot;~tc~ start ~/tc~&quot; stop=&quot;~tc~ end ~/tc~&quot;}
</code>
</pre></article></div></div><script src="/js/lightspa.js?v=1748177519"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1748177519",indexUrl:"/search/search_index.json.gz?v=1748177519"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/toc-sanitizer.js?v=1748177519"></script><script src="/js/search-results-panel.js?v=1748177519"></script><script src="/js/tiki-redirects.js?v=1748177519"></script></body></html>